EuGeni™ Rapid Diagnostic Platform
CE Certification- April 2021
SARS-CoV-2 Ag RDT 15-minute COVID-19 antigen rapid test has been approved for the platform, with a saliva-based test currently in validation.
EuGeni is a fast, accurate and compact solution for rapid point-of-care testing. With a small and portable benchtop design, it can be easily transported in the clinic and on the field for use by healthcare professionals.
In response to the global pandemic, we’ve introduced AnteoTech’s SARS-CoV-2 Ag rapid test as the first test to be used with EuGeni. Incorporating AnteoBind activated Europium, the test delivers optimal performance at 97.3% sensitivity1
Key features of the system include:
- Results analysis in 1 minute enabling mass-scale testing
- Fluorescent technology delivering strong detection signal
- Saliva-based sampling currently in development2
- Kit includes all materials: nasopharyngeal swabs, dropper bottle, test cassette
- Intuitive design with an easy-to-use colour touch screen
- Barcode scanner and printer option available3 increasing testing efficiency and reducing data errors